Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020

Archive ouverte

Williams, Thomas | Jackson, Sandra | Barr, Ian | Bi, Shabana | Bhiman, Jinal | Ellis, Joanna | von Gottberg, Anne | Lindstrom, Stephen | Peret, Teresa | Rughooputh, Sanjiv | Viegas, Mariana | Hirve, Siddhivinayak | Zambon, Maria | Zhang, Wenqing | Dia, Ndongo | Razanazatovo, Norosoa | Al-Nabet, Ajaeb Dakhilalla M. H. | Abubakar, Abdinasir | Tivane, Almiro | Barakat, Amal | Naguib, Amel | Aziz, Ammar | Vicari, Andrea | Moen, Ann | Govindakarnavar, Arunkumar | Hall, Aron | Darmaa, Badarch | Nathalie, Bastien | Herring, Belinda | Caetano, Braulia | Whittaker, Brett | Baumeister, Elsa | Nakouné, Emmanuel | Guthrie, Erica | Inbanathan, Francis | Nair, Harish | Campbell, Harry | Kadjo, Herve | Oumzil, Hicham | Heraud, Jean‐michel | Mott, Joshua | Namulondo, Joyce | Leite, Juliana | Nahapetyan, Karen | Al Ariqi, Lubna | Gazo, Mahmoud Hamad Ibraheem | Chadha, Mandeep | Pisareva, Maria | Venter, Marietjie | Siqueira, Marilda | Lumandas, Mayan | Niang, Mbayame | Albuaini, Mona | Salman, Muhammad | Oberste, Steve | Srikantiah, Padmini | Tang, Patrick | Couto, Paula | Smith, Peter | Coyle, Peter Valentine | Dussart, Philippe | Nguyen, Phuong Nam | Okada, Pilailuk Akkapaiboon | Wijesinghe, Pushpa Ranjan | Samuel, Reuben | Brown, Richard | Pebody, Richard | Fasce, Rodrigo | Jha, Runa | Gerber, Sue | Potdar, Varsha | Dong, Xiaomin | Deng, Yi Mo

Edité par CCSD ; Wiley Open Access -

Auteurs : WHO RSV Surveillance Group. International audience. BackgroundExternal quality assessments (EQAs) for the molecular detection of human respiratory syncytial virus (RSV) are necessary to ensure the standardisation of reliable results. The Phase II, 2019–2020 World Health Organization (WHO) RSV EQA included 28 laboratories in 26 countries. The EQA panel evaluated performance in the molecular detection and subtyping of RSV-A and RSV-B. This manuscript describes the preparation, distribution, and analysis of the 2019–2020 WHO RSV EQA.MethodsPanel isolates underwent whole genome sequencing and in silico primer matching. The final panel included nine contemporary, one historical virus and two negative controls. The EQA panel was manufactured and distributed by the UK National External Quality Assessment Service (UK NEQAS). National laboratories used WHO reference assays developed by the United States Centers for Disease Control and Prevention, an RSV subtyping assay developed by the Victorian Infectious Diseases Reference Laboratory (Australia), or other in-house or commercial assays already in use at their laboratories.ResultsAn in silico analysis of isolates showed a good match to assay primer/probes. The panel was distributed to 28 laboratories. Isolates were correctly identified in 98% of samples for detection and 99.6% for subtyping.ConclusionsThe WHO RSV EQA 2019–2020 showed that laboratories performed at high standards. Updating the composition of RSV molecular EQAs with contemporary strains to ensure representation of circulating strains, and ensuring primer matching with EQA panel viruses, is advantageous in assessing diagnostic competencies of laboratories. Ongoing EQAs are recommended because of continued evolution of mismatches between current circulating strains and existing primer sets.

Suggestions

Du même auteur

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

Archive ouverte | Tegally, Houriiyah | CCSD

International audience. INTRODUCTIONInvestment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of seque...

An early warning system for emerging SARS-CoV-2 variants

Archive ouverte | Subissi, Lorenzo | CCSD

International audience

A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa

Archive ouverte | Wilkinson, Eduan | CCSD

International audience. SARS-CoV-2 across Africa The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been hard to track in African countries, largely because of patchy data. W...

Chargement des enrichissements...